Moderna
MRNA
#1234
Rank
A$22.58 B
Marketcap
$58.69
Share price
3.55%
Change (1 day)
-50.10%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Net assets

Net assets on the balance sheet as of September 2024 : A$18.29 Billion

According to Moderna 's latest financial reports the company has A$18.29 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Moderna - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$20.33 B-27.64%
2022-12-31$A$28.10 B44.03%
2021-12-31$A$19.51 B485.81%
2020-12-31$A$3.33 B98.49%
2019-12-31$A$1.67 B-22.75%
2018-12-31$A$2.17 B171.2%
2017-12-31$A$0.80 B-31.42%
2016-12-31$A$1.16 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
A$0.15 B-99.18%๐Ÿ‡บ๐Ÿ‡ธ USA
A$68.36 B 273.61%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$55.85 Million-100.31%๐Ÿ‡บ๐Ÿ‡ธ USA
A$49.64 M-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
A$66.65 B 264.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$0.52 B-97.16%๐Ÿ‡บ๐Ÿ‡ธ USA
A$107.64 B 488.23%๐Ÿ‡บ๐Ÿ‡ธ USA